CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. - Wikidata - wikimedia - TriplyDB

CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.

CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.

http://www.wikidata.org/entity/Q45065873

about

Siglecs as sensors of self in innate and adaptive immune responses Siglecs and immune regulation CD22 and Siglec-G in B cell function and tolerance Rethinking mechanisms of autoimmune pathogenesis Comparative Transcriptomic Analysis of Rectal Tissue from Beef Steers Revealed Reduced Host Immunity in Escherichia coli O157:H7 Super-Shedders CD22: an inhibitory enigma Regulation of the gene encoding GPR40, a fatty acid receptor expressed selectively in pancreatic beta cells B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice.Augmented B lymphocyte response to antigen in the absence of antigen-induced B lymphocyte signaling in an IgG-transgenic mouse line Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.Loss of Siglec expression on T lymphocytes during human evolution.Differential roles of estrogen receptors α and β in control of B-cell maturation and selection.ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling B lymphocytes: how they develop and function.Characterizing the glycome of the mammalian immune system.Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation.The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone.Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice.Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation.Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis.Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.Epratuzumab (humanised anti-CD22 antibody) in autoimmune diseases.Sialic acids and autoimmune disease.Cis interactions of immunoreceptors with MHC and non-MHC ligands.Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling.The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions Regulation of B-cell entry into the cell cycle Dendritic cell-dependent inhibition of B cell proliferation requires CD22 Basic and clinical immunology of Siglecs A reevaluation of CD22 expression in human lung cancer.Physiological Exploration of the Long Term Evolutionary Selection against Expression of N-Glycolylneuraminic Acid in the Brain.Structural basis for recognition of cellular and viral ligands by NK cell receptors.

P2860

Q26829757-F82306EB-9E6E-4533-B538-41CD2853E6A1 Q26992091-DB3F899F-C602-4C3F-A6E3-9AD4B62529AF Q27016111-BFC25880-B9F8-423B-8A3A-7873A47CC83D Q27024290-3AF8DFB8-E8A6-4D4F-88AA-20A0A0496327 Q27317911-B6F5CF27-ED14-4E75-AF08-DF7E2F4477FA Q28260435-1B67ACEA-4E98-4469-84E9-D5097BDC6FEF Q28303815-07349D4D-4748-42EA-BFBF-246EE42DD985 Q28304887-7B072C44-DF0E-476B-AAEE-3CB7AE65447D Q31027910-0323CAA8-A05B-42EC-AAC0-A7CA8FB09E5A Q33526305-55ABDFF6-5B5A-4CEA-9B90-246032BFBBA1 Q33615157-4A6AF4E8-5FFF-47D6-BE74-F86FDC63C79E Q33673746-B1683884-1563-4790-BF5D-F4E5F1BF07C1 Q33883072-56145118-3704-4961-9EA0-33AA17DD23B1 Q34013562-4ECF4E91-E8D5-482E-8607-8DFFC95667F7 Q34650845-CB21ACC3-73EF-4759-8431-A103D730A259 Q34699508-FD1BC2FC-5668-4A73-9C47-900EA8DC0303 Q34718297-725EA217-CE72-4095-B14B-004AF4508F8D Q34813171-3BCB7EE7-6314-42F9-9400-ED03D958C0AD Q34813256-F59459F9-DD45-48FF-9D5C-78E692F1788F Q34940008-AE80CFFB-8DA9-498A-B2AD-6D4C08965DF1 Q34995766-0E8274E9-60F6-4AA2-8628-EF86AF697777 Q35484992-9F88BDD7-3E7C-438A-819A-AA7C29A0D9B9 Q35848710-083846E6-60EE-4885-96AF-8F10A22B5CA4 Q35856788-988C567C-5ACA-44EE-AEF7-5B5859942184 Q36238059-0B72C5E4-B09D-4EB4-BFE3-57722FC3767E Q36543703-EA77CD55-3B89-436D-B08A-2D5FDB007BCA Q36569755-A6F15128-CB4D-4809-9756-9ECABDE2CB43 Q36625410-0C585DDD-2A1C-4168-8F9B-11042A3AB469 Q36800512-4783C5AD-2986-4322-B081-0E9F5843EADA Q37031308-C267DA68-EC72-4EAD-8928-594A02B485CA Q37049344-81F3A1C4-8D15-4E8C-89F9-7EF4AE0EB043 Q37069155-33ADAE61-8D0A-4151-9F8C-8E4932745671 Q37072796-F8EABD93-7421-403A-8643-0CE19671445C Q37173667-A0BB29A7-8A9C-4F89-8612-F469E08B799A Q37256980-00E1A678-E43E-4D4E-B531-A3FFBB38605A Q37308334-CD651647-AFAF-447D-B5C4-54E456CE7658 Q37348437-4ED655C2-47D1-43FE-816E-45E81E91C9ED Q37518988-32957F46-9E47-48F0-85F3-A3224897DC14 Q37648392-6145BC98-9429-448E-AFBB-6979AA6160CC Q37678862-C1D02D60-0D7A-42CF-8C66-76BC02BAAC61

P2860

CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.

http://www.wikidata.org/entity/Q45065873

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

CD22 regulates B lymphocyte fu ...... ligand-independent mechanisms.

@en

CD22 regulates B lymphocyte fu ...... ligand-independent mechanisms.

@nl

type

label

CD22 regulates B lymphocyte fu ...... ligand-independent mechanisms.

@en

CD22 regulates B lymphocyte fu ...... ligand-independent mechanisms.

@nl

prefLabel

CD22 regulates B lymphocyte fu ...... ligand-independent mechanisms.

@en

CD22 regulates B lymphocyte fu ...... ligand-independent mechanisms.

@nl

P1433

Q45065873-8E9E1811-2FCC-4335-A30E-5CCF3693D3DE

P1476

Q45065873-74A943B6-E14B-4678-97AB-DAE331AD8989

P2093

Q45065873-0E33C1A6-AF36-4664-A03D-F37129A7BA70

Q45065873-420B6D52-BE87-4F98-A830-22A200CBF0E4

Q45065873-4AC97455-FC0C-4D8C-BE23-512179BAAC3C

Q45065873-4CD2CADF-155A-44F1-BE52-7E1C1C1AFEC7

Q45065873-639E9931-E75A-4260-96AE-73B244E5E945

Q45065873-80AD7533-7031-4FCD-9A32-C1CF473021AF

Q45065873-A1CA586F-9731-4DFC-975A-D43F14CB25F1

Q45065873-ACA30726-0FCF-40AE-8854-9DAF849902EA

Q45065873-DE6B0B13-CFB5-4493-978B-DA5C4E2DC566

P2860

Q45065873-02CA4928-26C3-4D0B-B8E5-D3B8E71D52B4

Q45065873-0B0664C5-7D5F-44A2-B786-0B912BBC440C

Q45065873-0F7C23F5-BA8E-462D-91FE-9164FDA8BBF9

Q45065873-1291E4FC-DE5F-4E9D-8280-49CE479601D8

Q45065873-176E04DE-7C56-41FC-9656-918BFA2216E7

Q45065873-332EB118-4A3E-45AC-803E-8D845ADF260F

Q45065873-35D8732A-6A14-4CEA-8E41-5F84B7558082

Q45065873-35FFE4AC-1555-4F87-B537-4001624A2CFD

Q45065873-3A368BBB-C2A3-4F9E-9FD4-F6C4DC85ACFB

Q45065873-42C0DE13-95B2-4823-886C-9F21226A9AE6

P304

Q45065873-0636BA42-0F52-4326-A1AF-50196B3DCEFF

P31

Q45065873-0D941AA1-6D6D-4E88-9363-D8A447B17496

P356

Q45065873-83DAA491-E1C0-4148-B85E-855299A900BD

P407

Q45065873-D6209392-B953-4A82-939C-ED062D7ACA0F

P433

Q45065873-1E93CEB7-40AD-442C-A696-42FF39AA8758

P478

Q45065873-005AA687-3413-4EC3-BB90-AE3A5C564C2F

P577

Q45065873-5EDEAB43-E4D0-4973-8EFC-2A2BF92A7C12

P5875

Q45065873-BE450297-72DC-4334-B686-902F03001A76

P698

Q45065873-F8A450C4-E9F6-4BAA-BB91-170597FFD535

P356

P1433

Nature Immunology

P1476

CD22 regulates B lymphocyte fu ...... ligand-independent mechanisms.

@en

P2093

Ann S Miller

http://www.w3.org/2001/XMLSchema#string

Cheryl B Bock

http://www.w3.org/2001/XMLSchema#string

Isaac G Sanford

http://www.w3.org/2001/XMLSchema#string

Jonathan C Poe

http://www.w3.org/2001/XMLSchema#string

Karen M Haas

http://www.w3.org/2001/XMLSchema#string

Manabu Fujimoto

http://www.w3.org/2001/XMLSchema#string

Minoru Hasegawa

http://www.w3.org/2001/XMLSchema#string

Thomas F Tedder

http://www.w3.org/2001/XMLSchema#string

Yoko Fujimoto

http://www.w3.org/2001/XMLSchema#string

P2860

CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation

Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22

The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase

CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux

Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily

CD22 is a negative regulator of B-cell receptor signalling

Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22

Hyperresponsive B cells in CD22-deficient mice

Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling

A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP

P304

1078-1087

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NI1121

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8336966

http://www.w3.org/2001/XMLSchema#string

P698

15378059

http://www.w3.org/2001/XMLSchema#string